Jordan J Green

This inventor holds 22 USPTO granted patents and 34 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Johns Hopkins University, Asclepix Therapeutics, Inc.. Active years: 2015-2026.

USPTO Granted Patents = 22 (Patent Applications = 34)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 18)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Columbia, MD (US) (2015 - 2024)
Nottingham, MD (US) (2017 - 2024)
Baltimore, MD (US) (2023 - 2024)

Company Filing History:

22 out of 3,795

Johns Hopkins University

patents

1 out of 1

Asclepix Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643980 - Poly(β-amino ester)-co-polyethylene glycol (PEG-PBAE-PEG) polymers for gene and drug delivery (2026-06-02),

2. 12642817 - Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases (2026-06-02),

3. 12605463 - Tolerogenic artificial antigen-presenting cells (2026-04-21),

4. 12527746 - PEPTIDE/PARTICLE DELIVERY SYSTEMS (2026-01-20),

5. 12371522 - Bioreducible poly (beta-amino ester)s for siRNA delivery (2025-07-29),

6. 12151000 - Tolerogenic artificial antigen-presenting cells (2024-11-26),

7. 12059476 - Biodegradable biomimetic particles (2024-08-13),

8. 12049530 - Multicomponent degradable cationic polymers (2024-07-30),

9. 11981754 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2024-05-14),

10. 11883541 - Nonviral gene transfer to the suprachoroidal space (2024-01-30),

11. 11697804 - Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy (2023-07-11),

12. 11674959 - Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors (2023-06-13),

13. 11547729 - Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases (2023-01-10),

14. 11401380 - Poly(β-amino ester)-co-polyethylene glycol (PEG-PBAE-PEG) polymers for gene and drug delivery (2022-08-02),

15. 10786463 - Peptide/particle delivery systems (2020-09-29),

Title: The Innovative Journey of Jordan J Green

Introduction: Jordan J Green is a renowned inventor based in Columbia, Maryland, known for his groundbreaking contributions to the field of biotechnology and medical devices.

Latest Patents: Jordan J Green holds several patents in the areas of drug delivery systems, biomaterials, and regenerative medicine, with his most recent patent focusing on a novel method for targeted drug delivery to cancer cells.

Career Highlights: With a background in biomedical engineering, Jordan J Green has had a successful career working at the intersection of science and technology. He has received numerous awards for his innovative research and has been recognized as a leading expert in his field.

Collaborations: Throughout his career, Jordan J Green has collaborated with top research institutions, pharmaceutical companies, and medical device manufacturers to bring his inventions to market. His collaborative approach has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Jordan J Green's passion for innovation and his dedication to improving healthcare through technology have solidified his reputation as a pioneering inventor in the field of biotechnology. His work continues to inspire the next generation of inventors and researchers in the quest for advancements in medical science.